Abiopharma

News list

GUGGENHIME ANDREW 🔴 sold 5.1K shares of Vaxcyte, Inc. (PCVX) at $31.56 Transaction Date: Sep 02, 2025 | Filing ID: 000007

Full text

News bot Sept. 4, 2025, 8:11 p.m.
🔍 GUGGENHIME ANDREW (Executive)

Company: Vaxcyte, Inc. (PCVX)

Report Date: 2025-09-02
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 5,080
Detailed Transactions and Holdings:
- Sold 1,270 shares of Common Stock at $31.56 per share (Direct)
  Date: 2025-09-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 131,009.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Sold 2,381 shares of Common Stock at $31.56 per share (Direct)
  Date: 2025-09-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 128,628.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 1,429 shares of Common Stock at $31.56 per share (Direct)
  Date: 2025-09-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 127,199.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
- F2: Includes 329 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2025.